Key Deal Facts
Treats 20+ neuromuscular (NM) conditions (stroke, cerebral palsy, chronic pain, incontinence)
Total market spend of $550B worldwide for NM conditions. Addressable market of $55B for JOGO
FDA cleared, patent with 18 claims. Medicare and insurance approved.
Co-Founder's previous AI venture was acquired by IQVIA, world's largest clinical research company
JOGO has already treated more than 2000 patients. Signed up 50+ hospital channel partners.
Medical Advisory Board is from Harvard, Yale, Boston University, Tufts, NYU and Columbia.
Part of Johnson & Johnson Innovation Incubator JLABS at University of Pennsylvania.
Co-Founder investing $495K in this round at same terms.